Medicare Enrolled

Dr. Charles King, M.D.

Urology Physician · Ocala, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
2850 SE THIRD COURT, Ocala, FL 34471
3527326474
In practice since 2005 (20 years)
NPI: 1871591388 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. King from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. King? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. King

Dr. Charles King is an urology physician in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. King performed 3,071 Medicare services across 2,459 unique beneficiaries.

Between the years covered by Open Payments, Dr. King received a total of $13,341 from 26 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. King is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in FL $13,341 industry payments

Florida License Status

FL DOH · MQA
2
Active licenses
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Emergency Medical Technician 585844 Clear December 1, 2026
Medical Doctor 50759 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
3,071
Medicare services
Top 34% in FL for urology physician
2,459
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~154 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
752 $3 $54
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
422 $66 $96
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
327 $92 $200
Injection, garamycin, gentamicin, up to 80 mg 207 $2 $7
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
204 $4 $21
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
203 $184 $565
Leuprolide acetate (for depot suspension), 7.5 mg 135 $135 $520
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
130 $30 $268
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
115 $11 $27
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
84 $0 $1
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $118 $259
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
63 $102 $357
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
62 $189 $598
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
56 $8 $193
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
45 $26 $70
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
44 $56 $72
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
42 $8 $8
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
30 $138 $250
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
26 $48 $80
Vancomycin injection, 500 mg
A 500 mg dose of vancomycin antibiotic is administered via injection.
26 $2 $3
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
14 $16 $50
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
13 $15 $35
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
21.4% medium
77.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,341
Total received (2018-2024)
Avg $1,906/year across 7 years
Top 17% in FL for urology physician
26
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$11,600 (86.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,616 (12.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$236
2023
$155
2022
$177
2021
$1,180
2020
$3,696
2019
$3,479
2018
$4,418

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Laser Specialty Medical, LLC
$11,600
Astellas Pharma US Inc
$378
ABBVIE INC.
$192
Myriad Genetic Laboratories, Inc.
$159
Sumitomo Pharma America, Inc.
$125
Janssen Biotech, Inc.
$108
Olympus America Inc.
$98
PFIZER INC.
$86
Allergan Inc.
$78
TOLMAR Pharmaceuticals, Inc.
$74
Augmenix, Inc.
$59
DENTSPLY IH Inc.
$50
Laborie Medical Technologies Corp.
$48
Ferring Pharmaceuticals Inc.
$38
AbbVie, Inc.
$33
180 Medical, Inc.
$27
Baxter Healthcare
$27
Allergan, Inc.
$23
UroGen Pharma, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
TherapeuticsMD, Inc.
$20
Boston Scientific Corporation
$19
ACCORD HEALTHCARE, INC.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Blue Earth Diagnostics Limited
$14
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 91.2% of total payments
Associated products mentioned in payments ›
Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · ELIGARD · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · IMVEXXY · JELMYTO · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Natesto · Nubeqa · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · Prolaris · SpaceOAR · TACHOSIL · TOVIAZ · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Equivalent to $434 per 100 Medicare services performed
Looking for an urology physician in Ocala?
Compare urology physicians in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
28
Per 100K population
7.2
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. King is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 17% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. King experienced with urinalysis, manual?
Based on Medicare claims data, Dr. King performed 752 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. King receive payments from pharmaceutical companies?
Yes. Dr. King received a total of $13,341 from 26 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. King's costs compare to other urology physicians in Ocala?
Dr. King's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. King) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →